Feasibility Trial in Urban Pakistan for Community Engagement in Preventing Type II Diabetes and Risk Factors

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20+
SponsorBaqai Institute of Diabetology and Endocrinology

About this trial

This project aims to adapt, implement, and evaluate PLA based intervention in urban Karachi, Pakistan for TIIDM prevention and control.

Eligibility criteria

Qualifiers

Individuals aged 20 years and above.

Participants residing in the randomized clusters of Karachi, Pakistan

Individuals willing to participate in the study and provide consent.

Both individuals with normoglycemia, intermediate hyperglycemia, and diabetes are encouraged to participate.

Disqualifiers

Individuals below the age of 20 years.

Individuals unwilling to provide consent for participation.

Participants with severe health conditions that may hinder their active involvement in the study.

Individuals with non-compliance with research protocols

Trial design

Treatments tested in this trial

  • Participatory, learning and Action (PLA) Based intervention

Treatment groups

240 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Baqai Institute of Diabetology and Endocrinology

Lead sponsor

University of York

Collaborator

Khyber Medical University Peshawar

Collaborator

HealthNet TPO

Collaborator

National Institute for Health Research, United Kingdom

Collaborator

Aga Khan University Hospital, Pakistan

Collaborator